Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

72.50p

Change Today:

-16.00p
52 Week High: 92.50
52 Week Low: 55.80

Currency: UK Pounds
Shares Issued: 37.76m
Volume: 94,553

Market Cap: £27.37m
Beta: 0.00

Trade now with Barclays Stockbrokers

Update - Arecor Therapeutics is down today can you capitalise from spread betting? Find out more
Update - Arecor Therapeutics is near the bottom of the FTSE AIM - will it stay here? Have a look at Arecor Therapeutics 's chart Find out more
Update - Arecor Therapeutics is a top faller in its sector - can you take advantage with spread betting? Find out more
Update - Arecor Therapeutics 's interim report is due soon - find out more Find out more

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart

6 Month Chart

More Arecor Therapeutics charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	54.4%	n/a
ROCE	14.2%

	Latest	F'cast
P/E	32.1	n/a
PEG	n/a	n/a
Pr/Revenue	14.2	n/a
Pr/Book	3.8

	Latest	F'cast
Revenue	4.3%	n/a
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

AREC Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	1.16	(6.95)	(27.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	2.40	(10.54)	(32.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	4.57	(8.90)	(0.28)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	1.64	(5.09)	(16.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	1.71	0.99	2.00p	40.3	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

Retail Offer to raise up to £130,000	30-Sep-2026	15:00	RNS
Results of Placing	30-Sep-2026	14:58	RNS
Close of Accelerated Bookbuild to New Orders	30-Sep-2026	13:29	RNS

More Arecor Therapeutics arec company announcements

AREC ShareCast News

Arecor enters formulation partnership with Skye ...	19-May-2025	ShareCast
Arecor enters collaboration with unnamed global ...	26-Mar-2025	ShareCast
Revenue higher, cash reserves fall at Arecor	03-Feb-2025	ShareCast

More Arecor Therapeutics ShareCast news

Latest AREC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

AREC Market Data

Currency	UK Pounds
Share Price	72.50p
Change Today	-16.00p
% Change	-18.08 %
52 Week High	92.50
52 Week Low	55.80
Volume	94,553
Shares Issued	37.76m
Market Cap	£27.37m
Beta	0.00